PEP223

· Pepscan Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEP223, covering 2009-05-08 to 2009-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients [Phase 1, Phase 2]